Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
![](../../images/overlap_matrix_icon.png)
8
Number of overlapping holdings
36.4%
% of PJP's 22 holdings also in MEDX
26.7%
% of MEDX's 30 holdings also in PJP
Overlap by Weight
Sector Drift (PJP minus MEDX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in PJP |
Weight in MEDX |
Overlap | |
---|---|---|---|---|
ABBVIE INC | 6.2% | 7.4% | 6.2% | |
AMGEN INC | 6.2% | 6.2% | 6.2% | |
ELI LILLY & CO | 6.0% | 16.0% | 6.0% | |
MERCK & CO. INC. | 5.6% | 4.7% | 4.7% | |
JOHNSON & JOHNSON | 6.0% | 4.4% | 4.4% |
Position Highlights (Non-Overlapping Exposures)
PJP Overweight Relative to MEDX
ABBOTT LABORATORIES | 5.6% | |
GERON CORP | 4.8% | |
UNITED THERAPEUTICS CORP | 4.3% | |
LIGAND PHARMACEUTICALS-CL B | 4.0% | |
GILEAD SCIENCES INC | 4.0% | |
PRESTIGE BRANDS HOLDINGS INC | 3.9% | |
SUPERNUS PHARMACEUTICALS INC | 3.9% | |
INNOVIVA, INC. | 3.9% | |
CORCEPT THERAPEUTICS INC | 3.7% | |
JAZZ PHARMACEUTICALS PLC | 3.6% |
PJP Underweight Relative to MEDX
ELI LILLY & CO | -10.0% | |
NOVARTIS AG-ADR | -5.7% | |
ASTRAZENECA PLC-SPONS ADR | -5.5% | |
BRISTOL-MYERS SQUIBB CO | -4.2% | |
ALNYLAM PHARMACEUTICALS INC | -3.8% | |
IONIS PHARMACEUTICALS, INC. | -3.3% | |
CRISPR THERAPEUTICS AG | -3.2% | |
ALKERMES PLC | -3.2% | |
GLAXOSMITHKLINE PLC-SPON ADR | -2.5% | |
INTELLIA THERAPEUTICS, INC. | -2.0% |